Literature DB >> 11093412

New developments in endovascular interventions for extracranial carotid stenosis.

W A Tan1, C R Jarmolowski, L R Wechsler, M H Wholey.   

Abstract

We provide an overview of recent developments in carotid interventional technique and equipment, including new stents and emboli protection devices. The newer self-expanding stents lessen the problem of external stent compression associated with balloon expandable stents, but precise deployment and the matching (by length) of stents to lesions remain problematic. We also discuss emerging pharmacologic strategies for cerebral protection in stroke. Multiple randomized clinical trials and multicenter registries are under way to compare percutaneous with surgical strategies for the treatment of carotid stenosis. These include the evaluation of emboli protection devices, and, to a lesser degree, intravenous glycoprotein IIb/IIIa antagonists. Other clinical trials are aimed towards refining the ability to stratify patients by risk, in order to identify the subsets that would benefit most from these complex and expensive procedures.

Entities:  

Mesh:

Year:  2000        PMID: 11093412      PMCID: PMC101079     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  62 in total

1.  Prediction of benefit from carotid endarterectomy in individual patients: a risk-modelling study. European Carotid Surgery Trialists' Collaborative Group.

Authors:  P M Rothwell; C P Warlow
Journal:  Lancet       Date:  1999-06-19       Impact factor: 79.321

2.  Carotid wall thickness is predictive of incident clinical stroke: the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  L E Chambless; A R Folsom; L X Clegg; A R Sharrett; E Shahar; F J Nieto; W D Rosamond; G Evans
Journal:  Am J Epidemiol       Date:  2000-03-01       Impact factor: 4.897

3.  Current global status of carotid artery stent placement.

Authors:  M H Wholey; M Wholey; P Bergeron; E B Diethrich; M Henry; J C Laborde; K Mathias; S Myla; G S Roubin; F Shawl; J G Theron; J S Yadav; G Dorros; J Guimaraens; R Higashida; V Kumar; M Leon; M Lim; H Londero; J Mesa; S Ramee; A Rodriguez; K Rosenfield; G Teitelbaum; C Vozzi
Journal:  Cathet Cardiovasc Diagn       Date:  1998-05

4.  [Catheter treatment of arterial occlusive disease of supraaortic vessels].

Authors:  K Mathias
Journal:  Radiologe       Date:  1987-12       Impact factor: 0.635

5.  Safety and tolerability of the glutamate antagonist CGS 19755 (Selfotel) in patients with acute ischemic stroke. Results of a phase IIa randomized trial.

Authors:  J Grotta; W Clark; B Coull; L C Pettigrew; B Mackay; L B Goldstein; I Meissner; D Murphy; L LaRue
Journal:  Stroke       Date:  1995-04       Impact factor: 7.914

6.  Multinational randomised controlled trial of lubeluzole in acute ischaemic stroke. European and Australian Lubeluzole Ischaemic Stroke Study Group.

Authors:  H C Diener
Journal:  Cerebrovasc Dis       Date:  1998 May-Jun       Impact factor: 2.762

7.  Genetically engineered endothelial cells remain adherent and viable after stent deployment and exposure to flow in vitro.

Authors:  M Y Flugelman; R Virmani; M B Leon; R L Bowman; D A Dichek
Journal:  Circ Res       Date:  1992-02       Impact factor: 17.367

8.  Complications of cerebral angiography in patients with symptomatic carotid territory ischaemia screened by carotid ultrasound.

Authors:  K N Davies; P R Humphrey
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-09       Impact factor: 10.154

9.  Reduction in thrombotic events with heparin-coated Palmaz-Schatz stents in normal porcine coronary arteries.

Authors:  P A Hårdhammar; H M van Beusekom; H U Emanuelsson; S H Hofma; P A Albertsson; P D Verdouw; E Boersma; P W Serruys; W J van der Giessen
Journal:  Circulation       Date:  1996-02-01       Impact factor: 29.690

10.  Clinical and angiographic predictors of stroke and death from carotid endarterectomy: systematic review.

Authors:  P M Rothwell; J Slattery; C P Warlow
Journal:  BMJ       Date:  1997-12-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.